Elevated CRP levels indicate poor progression-free and overall …

Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors ... studied, the predictive meaning of systemic inflam-matory status in patients receiving immune check-point inhibitors (ICIs) is inadequately defined. Blood-based markers of systemic inflammation are shown to predict treatment benefit on cancer pa-tients treated with ICIs but the … ................
................